![](/img/cover-not-exists.png)
Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human α1-antitrypsin
Eeva Piitulainen, Elisabeth Bernspång, Sven Björkman, Erik BerntorpVolume:
59
Language:
english
Pages:
6
DOI:
10.1007/s00228-003-0589-z
Date:
June, 2003
File:
PDF, 272 KB
english, 2003